search icon

    Market Snapshot

    blog search icon

    Kinnate Biopharma Inc. Performance, Technical Analysis and Valuation

    Kinnate Biopharma Inc.

    (NASDAQ:KNTE)

    $7.37

    -0.16 (-2.12%)

    At Close: 4:00 PM

    $7.37

    0.00 (0.00%)

    After Market: 7:49 PM

    Kinnate Biopharma Inc. 1 Year - Performance

    Kinnate Biopharma Inc.

    The price of a stock is the truest depiction of a company's value and what the market anticipates about its performance. A stock's market value is critical, but the process is plagued with uncertainty, leading to investor skepticism.

    However, in today's economic environment, investors may learn a lot about the market expectations of their target stocks by looking at stock's performance and important indicators.

    Comparing their expectations to the market could help investors estimate their prospective return.

    Performance

    Period

    • 1 Week
    • 1 Month
    • Quarter
    • Half Year
    • 1 Year
    • YTD

    High

    • -
    • -
    • -
    • -
    • -
    • -

    Low

    • -
    • -
    • -
    • -
    • -
    • -

    Performance

    • 0.96%
    • 20.62%
    • -12.16%
    • -44.08%
    • -21.93%
    • 20.82%

    KNTE Fundamental Analysis

    • ATR0.55
    • Enterprise Value0
    • Avg Vol (3 Months)122.43K
    • Avg Vol (10 Days)94.69K

    52-Week Performance

    • 52-Week High15.86
    • 52-Week Low5.17
    • 52-Week Chg-
    • S&P 500 52-Week Chg-

    Valuation

    Valuation

    • P/E (TTM)info icon
    • P/C (MRQ)info icon
    • P/S (TTM)info icon
    • P/B (MRQ)info icon

    KNTE

    • -
    • 1.34
    • -
    • 1.31

    Industry Avg

      Sector Median

        S&P 500

          KNTE Technical Analysis

          • SMA 209.37%
          • SMA 5010.74%
          • SMA 200-24.86%
          • RSI (14)57.9

          Frequently Asked Questions

          icon

          How is KNTE price-to-earnings ratio currently?

          KNTE has a current P/E ratio of N/A.

          icon

          How are KNTE's price-to-sale and price-to-book ratios?

          The KNTE stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 1.31.

          icon

          Is Kinnate Biopharma Inc.'s price-to-cash ratio high or low?

          KNTE's price-to-cash (P/C) ratio is 1.34, an indicator that is currently being trending upward.

          icon

          What's current simple moving average (SMA) for KNTE?

          Based on KNTE's recent bid, its distance from 20 days simple moving average is 9.37%. It is 10.74% apart from 50 days simple moving average, and it is -24.86% apart from 200 days simple moving average.

          icon

          What is the 52-week price range for KNTE?

          The 52-week high for KNTE is $15.86 which is 0.54% away from the current price level whereas the distance of that from the 52-week low of $5.17 stands at 0.43%.

          icon

          An overview of KNTE's stock performance: how did it fare?

          The performance of KNTE stock was not encouraging with most of its significant price indictors in red. Kinnate Biopharma Inc. (NASDAQ: KNTE) shares have moved downward -2.12% or -$0.16 in the latest trading session and have gained 20.82% year-to-date (YTD). The stock has loss nearly -21.93% over the past year. After moving -12.16% over the trailing 3-month period, the stock is -44.08% lower in the 6-month period. Looking at its performance over the shorter term, it's up 0.96% a week and 20.62% a month.

          icon

          What is KNTE's 14-day relative strength index (RSI)?

          The current 14-day RSI for KNTE stock is 57.90. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.

          icon

          For KNTE, what is the average true range (ATR) for the past two weeks?

          ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Kinnate Biopharma Inc. (KNTE) has a 14-day ATR of 0.55.

          icon

          What is KNTE's current enterprise value?

          After closing at $7.37 with 44.15 Million of its shares outstanding, the current enterprise value of KNTE is roughly N/A.

          icon

          Over the past year, how has the stock price of KNTE changed?

          Kinnate Biopharma Inc. (NASDAQ: KNTE) is up N/A when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of N/A. KNTE stock price is also up 20.82% on its value in year-to-date trading.

          icon

          What is the average trading volume for KNTE shares?

          The number outstanding shares of KNTE is 44.15 Million, and of these 43.94 Million shares are freely available for trading. On average, KNTE stock has traded 94.69 Thousands shares per day for the past 10 days. A total of 366.44 Thousands shares changed hands during the last trading session with the average session volume of 122.43 Thousands shares.